The U.S. Food and Drug Administration (FDA) has authorized or approved several antiviral medications to treat mild-to-moderate COVID-19. These therapies are for use in individuals who are at high risk of getting severe disease if infected with COVID-19.
People who are more likely to get very sick include:
- Older adults (especially those ages 65 years or older, with risk increasing with advancing age)
- People who are unvaccinated or are not up to date on their COVID-19 vaccinations
- People with certain medical conditions, such as chronic lung disease, heart disease or a weakened immune system
Most individuals with COVID-19 have mild illness and can recover at home without medical care. These medications are available through a prescription from your primary care provider.
These treatments are not alternatives to getting vaccinated or wearing a mask.
For more information, please refer to the Types of COVID-19 Treatment Options page on the CDC website.
Note: Paxlovid is endorsed for use for pregnant women by the Society for Maternal Medicine and by the American College of Obstetrics and Gynecology. Please contact your primary care provider to determine your best treatment option for COVID-19.
If you have any questions after your treatment about side effects or your COVID-19 symptoms, please follow up with your primary care provider.
If you have questions about your insurance coverage, please contact your insurance company. Dartmouth Health provides financial assistance for those who are unable to pay for their medical care based on their individual financial situation. Pfizer also provides financial assistance through their Paxcces Patient Support Program.